Gland Pharma Share Price

1,937.8020.21 (1.06%)
Volume: 51,691

Closed
Last Updated On: 17 Oct, 2025, 03:42 PM IST

TECHNICALS
COMPARE

1,937.8020.21 (1.06%)
Volume: 51,691

Stock Recommendations

Potential
Upside
1 Year
Target

HOLD

Mean Recos by
13 Analysts

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

/10

Stock Score

View Report

Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum

No Rating (NR)

Negative

Neutral

Positive

Unlock Stock Score

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Key Metrics

PE Ratio

(x)

41.45

EPS - TTM

(₹)

46.75

MCap

(₹ Cr.)

31,926.50

Sectoral MCap Rank

PB Ratio

(x)

3.45

Div Yield

(%)

0.00

Face Value

(₹)

1.00

Beta

VWAP

(₹)

1,931.13

52W H/L

(₹)

2,131.00 / 1,277.80

Gland Pharma share price insights

View All

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 24.95% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Buy Signal: Bulls on driving seat
50 day moving crossover appeared on Oct 17, 2025. Average price gain of 6.12% within 30 days of this signal in last 5 years.
Buy Signal: Bullish trend in offing
5 day moving crossover appeared on Oct 17, 2025. Average price gain of 3.46% within 7 days of this signal in last 5 years.
Gland Pharma Share Price Update
Gland Pharma Ltd. share price moved up by 1.06% from its previous close of Rs 1,917.60. Gland Pharma Ltd. stock last traded price is 1,937.80
Share Price Value
Today/Current/Last 1,937.801,936.10
Previous Day 1,917.601,920.00

Share Price	Value
Today/Current/Last	1,937.801,936.10
Previous Day	1,917.601,920.00

InsightsGland Pharma

Do you find these insights useful?

hate it
meh
love it

Gland Pharma Share Price Returns

1 Day	1.06%
1 Week	0.75%
1 Month	-2.47%
3 Months	-3.48%
1 Year	18.18%
3 Years	-10.16%
5 Years	N.A.

ET Stock ScreenersTop Score Companies

Check whether Gland Pharma belongs to analysts' top-rated companies list?

View Stock Screeners

Gland Pharma News & Analysis

View all Gland Pharma Share News & Announcements

Gland Pharma Share Recommendations

Recent Recos

HOLD

Current

Mean Recos by 13 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹1970
OrganizationMotilal Oswal Securities
BUY

Target₹2440
OrganizationMotilal Oswal Financial Services
BUY

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	3	3	3	4
Buy	3	3	3	1
Hold	3	3	3	1
Sell	3	3	3	3
Strong Sell	1	1	1	2
# Analysts	13	13	13	11

View all Stock Recommendations

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 24.95% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	1,563.15	1,468.94	1,442.55	1,465.49	1,453.14
Total Income Growth (%)	6.41	1.83	-1.57	0.85	-8.01
Total Expenses	1,238.91	1,173.16	1,120.42	1,202.60	1,229.28
Total Expenses Growth (%)	5.61	4.71	-6.83	-2.17	-3.31
EBIT	324.24	295.78	322.12	262.89	223.86
EBIT Growth (%)	9.62	-8.18	22.53	17.43	-27.36
Profit after Tax (PAT)	215.48	186.54	204.69	163.53	143.76
PAT Growth (%)	15.51	-8.87	25.17	13.75	-25.29
EBIT Margin (%)	20.74	20.14	22.33	17.94	15.41
Net Profit Margin (%)	13.79	12.70	14.19	11.16	9.89
Basic EPS (₹)	13.08	11.32	12.42	9.93	8.73

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	1,093.58	1,074.07	1,075.85	1,120.79	1,060.51
Total Income Growth (%)	1.82	-0.16	-4.01	5.68	-13.20
Total Expenses	723.76	679.30	663.41	740.81	759.29
Total Expenses Growth (%)	6.54	2.40	-10.45	-2.43	-3.22
EBIT	369.82	394.77	412.44	379.99	301.23
EBIT Growth (%)	-6.32	-4.28	8.54	26.15	-31.10
Profit after Tax (PAT)	269.26	290.00	295.12	281.71	222.92
PAT Growth (%)	-7.15	-1.74	4.76	26.37	-30.64
EBIT Margin (%)	33.82	36.75	38.34	33.90	28.40
Net Profit Margin (%)	24.62	27.00	27.43	25.13	21.02
Basic EPS (₹)	16.34	17.60	17.91	17.10	13.53

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	5,830.11	5,834.96	3,865.06	4,624.65	3,597.65
Total Revenue Growth (%)	-0.08	50.97	-16.42	28.55	29.77
Total Expenses	4,767.45	4,702.42	2,754.02	3,006.09	2,262.84
Total Expenses Growth (%)	1.38	70.75	-8.39	32.85	27.16
Profit after Tax (PAT)	698.53	772.46	781.04	1,211.66	996.96
PAT Growth (%)	-9.57	-1.10	-35.54	21.54	29.00
Operating Profit Margin (%)	19.66	20.45	30.85	36.89	38.64
Net Profit Margin (%)	12.43	13.63	21.54	27.53	28.79
Basic EPS (₹)	42.40	46.90	47.44	73.81	63.07

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	4,331.22	4,334.09	3,856.99	4,624.65	3,597.65
Total Revenue Growth (%)	-0.07	12.37	-16.60	28.55	29.77
Total Expenses	2,865.64	2,928.60	2,752.13	3,005.61	2,262.80
Total Expenses Growth (%)	-2.15	6.41	-8.43	32.83	27.16
Profit after Tax (PAT)	1,089.75	1,043.33	775.83	1,212.16	997.01
PAT Growth (%)	4.45	34.48	-36.00	21.58	29.00
Operating Profit Margin (%)	36.16	33.91	30.75	36.90	38.64
Net Profit Margin (%)	26.47	25.03	21.45	27.54	28.79
Basic EPS (₹)	66.15	63.35	47.12	73.84	63.07

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	11,224.92	10,661.25	8,777.54	7,833.62	6,496.08
Total Assets Growth (%)	5.29	21.46	12.05	20.59	58.98
Total Liabilities	2,074.18	1,937.40	818.81	676.00	592.84
Total Liabilities Growth (%)	7.06	136.61	21.13	14.03	34.80
Total Equity	9,150.74	8,723.84	7,958.72	7,157.62	5,903.24
Total Equity Growth (%)	4.89	9.61	11.19	21.25	61.90
Current Ratio (x)	4.33	4.04	9.46	10.05	10.00
Total Debt to Equity (x)	0.03	0.04	0.00	0.00	0.00
Contingent Liabilities	184.34	100.73	128.46	124.53	74.70

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	10,421.62	9,541.09	8,773.18	7,834.14	6,496.06
Total Assets Growth (%)	9.23	8.75	11.99	20.60	58.98
Total Liabilities	666.52	545.80	819.88	675.91	592.77
Total Liabilities Growth (%)	22.12	-33.43	21.30	14.03	34.78
Total Equity	9,755.10	8,995.29	7,953.30	7,158.23	5,903.29
Total Equity Growth (%)	8.45	13.10	11.11	21.26	61.90
Current Ratio (x)	11.01	11.04	9.43	10.04	10.00
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	114.68	100.73	128.46	124.53	219.23

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	914.73	996.80	363.97	790.77	604.93
Net Cash used in Investing Activities	1,704.74	-1,756.91	1,208.19	-1,002.62	-1,524.00
Net Cash flow from Financing Activities	-433.48	-799.42	14.92	34.90	1,238.46
Net Cash Flow	2,199.12	-1,551.81	1,590.08	-173.64	322.97
Closing Cash & Cash Equivalent	2,556.21	357.09	1,908.90	318.82	492.46
Closing Cash & Cash Equivalent Growth (%)	615.85	-81.29	498.74	-35.26	190.54
Total Debt/ CFO (x)	0.29	0.32	0.01	0.00	0.01

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1,073.67	1,135.97	367.89	791.29	604.93
Net Cash used in Investing Activities	1,578.20	-2,923.92	1,208.22	-1,010.23	-1,524.55
Net Cash flow from Financing Activities	-339.54	-7.40	14.92	34.90	1,238.46
Net Cash Flow	2,316.42	-1,789.01	1,594.04	-180.73	322.42
Closing Cash & Cash Equivalent	2,432.62	116.21	1,905.22	311.18	491.92
Closing Cash & Cash Equivalent Growth (%)	1,993.39	-93.90	512.25	-36.74	190.22
Total Debt/ CFO (x)	0.00	0.00	0.01	0.00	0.01

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	7.63	8.85	9.81	16.92	16.88
Return on Capital Employed (%)	11.43	12.50	13.89	22.39	22.36
Return on Assets (%)	6.22	7.24	8.89	15.46	15.34
Interest Coverage Ratio (x)	35.30	57.38	169.90	330.81	392.33
Asset Turnover Ratio (x)	0.51	0.58	0.44	0.61	53.30
Price to Earnings (x)	37.59	39.37	26.81	44.44	40.82
Price to Book (x)	2.87	3.48	2.63	7.50	6.87
EV/EBITDA (x)	16.15	19.17	13.54	29.19	26.12
EBITDA Margin (%)	26.39	26.53	34.90	39.40	41.49

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	11.17	11.59	9.75	16.93	16.88
Return on Capital Employed (%)	15.03	15.48	13.82	22.39	22.36
Return on Assets (%)	10.45	10.93	8.84	15.47	15.34
Interest Coverage Ratio (x)	72.59	200.87	169.82	331.03	392.34
Asset Turnover Ratio (x)	0.41	0.46	0.44	0.61	53.30
Price to Earnings (x)	24.10	29.15	26.95	44.44	40.82
Price to Book (x)	2.69	3.37	2.63	7.50	6.87
EV/EBITDA (x)	14.36	18.24	13.61	29.19	26.12
EBITDA Margin (%)	40.27	37.80	34.81	39.41	41.49

Financial InsightsGland Pharma

Income (P&L)

- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 24.95% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Gland Pharma Share Price Forecast

Price
Revenue
Earnings

Get multiple analysts’ prediction on Gland Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Gland Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Gland Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Gland Pharma Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Bullish / Bearish signals for Gland Pharma basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 17 Oct 2025
5D EMA: 1931.70
Last 4 Buy Signals:15 Oct 2025
Date 7 days Gain/Loss %
15 Oct 2025 0.38%
8 Oct 2025 0.64%
29 Sep 2025 2.15%
18 Sep 2025 1.91%
Average price gain of 3.41% within 7 days of Bullish signal in last 5 years
50 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 17 Oct 2025
50D EMA: 1937.45
Last 4 Buy Signals:9 Sep 2025
Date 30 days Gain/Loss %
9 Sep 2025 7.96%
5 Sep 2025 0.91%
20 May 2025 21.26%
24 Mar 2025 2.35%
Average price gain of 5.95% within 30 days of Bullish signal in last 5 years
Heikin-Ashi Changeover
Bullish indication on daily chart
Prev. Close Price
1930.88
LTP
1937.80
Formed on:

Date	7 days Gain/Loss %
15 Oct 2025	0.38%
8 Oct 2025	0.64%
29 Sep 2025	2.15%
18 Sep 2025	1.91%

Date	30 days Gain/Loss %
9 Sep 2025	7.96%
5 Sep 2025	0.91%
20 May 2025	21.26%
24 Mar 2025	2.35%

Gland Pharma Peer Comparison

Gland Pharma Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Gland Pharma Stock Performance	1.06	0.75	-2.47	-3.48	18.18	-10.16	0.00
Suven Pharma Stock Performance	-0.94	-1.64	-7.91	-18.87	-28.80	125.28	153.58
Ipca Labs Stock Performance	-0.17	-3.61	-1.90	-12.74	-21.91	44.03	21.85
Ajanta Pharma Stock Performance	-0.81	0.18	-4.78	-12.49	-24.66	93.92	137.35
J B Chemicals Stock Performance	1.33	1.20	0.02	1.76	-10.14	76.93	223.14
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Gland Pharma	41.45	3.49	7.63	11.43	6.22	7.94	19.66	12.43	42.40	4.33	0.03	0.29
Suven Pharma	133.00	18.50	15.78	13.36	8.83	-3.80	29.74	22.10	10.52	2.43	0.05	0.27
Ipca Labs	41.91	3.89	10.61	15.15	6.27	15.11	15.89	8.80	35.14	2.63	0.19	0.99
Ajanta Pharma	32.76	8.04	24.28	30.10	18.35	11.00	26.02	19.80	73.56	2.85	0.00	0.00
J B Chemicals	38.71	7.72	19.21	24.69	15.43	16.92	22.94	16.83	42.45	3.04	0.00	0.02
Add More

Annual Ratios (%)

Choose from Peers

Syngene Int.
Piramal Pharma
Emcure Pharmaceuticals Ltd.
Wockhardt
Eris Lifesciences

Choose from Stocks

See All Parameters

Peers InsightsGland Pharma

Do you find these insights useful?

hate it
meh
love it

Gland Pharma Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Gland Pharma Shareholding as on Sep 2025
Category Sep 2025 Jun 2025 Mar 2025 Dec 2024
Promoters 51.83 51.83 51.83 51.83
Pledge 0.00 0.00 0.00 0.00
FII 7.89 7.39 6.90 5.04
DII 32.62 32.86 33.27 34.80
Mutual Funds 30.19 30.67 31.16 32.37
Others 7.65 7.92 8.00 8.33
Showing Shareholding as on Sep 2025
Category No. of Shares Percentage % Change QoQ
Promoters 8,53,93,934 51.83 % 0.00
Pledge 0 0.00 % 0.00
FII 1,30,28,669 7.89 % 0.50
DII 5,37,48,921 32.62 % -0.23
MF 4,97,37,890 30.19 % -0.48
Others 1,25,84,899 7.65 % -0.26

Category	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Promoters	51.83	51.83	51.83	51.83
Pledge	0.00	0.00	0.00	0.00
FII	7.89	7.39	6.90	5.04
DII	32.62	32.86	33.27	34.80
Mutual Funds	30.19	30.67	31.16	32.37
Others	7.65	7.92	8.00	8.33

Category	No. of Shares	Percentage	% Change QoQ
Promoters	8,53,93,934	51.83 %	0.00
Pledge	0	0.00 %	0.00
FII	1,30,28,669	7.89 %	0.50
DII	5,37,48,921	32.62 %	-0.23
MF	4,97,37,890	30.19 %	-0.48
Others	1,25,84,899	7.65 %	-0.26

Gland Pharma MF Ownership

HDFC Mid Cap Direct-G
Equity: Mid Cap
5
- 1,167.11
  Amount Invested (in Cr.)
- 1.38%
  % of AUM
- 0.30
  % Change (MoM basis)
SBI Large & Midcap Direct-G
Equity: Large & MidCap
4
- 631.34
  Amount Invested (in Cr.)
- 1.85330475%
  % of AUM
- 0.00
  % Change (MoM basis)
Mirae Asset Large & Midcap Direct-G
Equity: Large & MidCap
2
- 578.76
  Amount Invested (in Cr.)
- 1.41776498%
  % of AUM
- -0.05
  % Change (MoM basis)

MF Ownership as on 30 September 2025

View all Mutual Fund Schemes

Gland Pharma Corporate Actions

Gland Pharma Board Meeting/AGM
Gland Pharma Dividends
Others

Meeting Date	Announced on	Purpose	Details
Aug 28, 2025	May 20, 2025	AGM	-
Aug 05, 2025	Jul 21, 2025	Board Meeting	Quarterly Results
May 20, 2025	May 06, 2025	Board Meeting	Audited Results & Final Dividend
Apr 01, 2025	Feb 28, 2025	POM	-
Mar 11, 2025	Feb 07, 2025	POM	-

Type Dividend Dividend per Share Ex-Dividend Date Announced on
Final 1800% 18.0 Aug 14, 2025 May 20, 2025
Final 2000% 20.0 Aug 16, 2024 May 22, 2024
No other corporate actions details are available.

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	1800%	18.0	Aug 14, 2025	May 20, 2025
Final	2000%	20.0	Aug 16, 2024	May 22, 2024

About Gland Pharma

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 31,926.50 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2025. Show More

Executives
Auditors

SS
Srinivas Sadu
Executive Chairman
SG
Shyamakant Giri
Chief Executive Officer
JA
Jia Ai (Allen) Zhang
Non Exe.Non Ind.Director
WH
Wei Huang
Non Exe.Non Ind.Director
WZ
Wenjie Zhang
Non Exe.Non Ind.Director
EG
Essaji Goolam Vahanvati
Independent Director
NL
Naina Lal Kidwai
Independent Director
SM
Satyanarayana Murthy Chavali
Independent Director
UJ
Udo Johannes Vetter
Independent Director
RS
Ravi Shekhar Mitra
Chief Financial Officer
SS
Satnam Singh Loomba
Chief Operating Officer
PS
P Sampath Kumar
Co. Secretary & Compl. Officer
Show More
Deloitte Haskins & Sells
S R Batliboi & Associates LLP

Industry

Pharma - Indian

Key Indices Listed on

Nifty 500, BSE 500, Nifty Pharma, + 19 more

Address

Sy.No. 143-148, 150 & 151,Near Gandi Maisamma �X� Roads,Hyderabad, Telangana - 500043

Contact

[email protected]

https://www.glandpharma.com

More Details

FAQs about Gland Pharma share

1. What's Gland Pharma share price today and what are Gland Pharma share returns ?
Gland Pharma share price is Rs 1,937.80 as on 17 Oct, 2025, 03:58 PM IST. Gland Pharma share price is up by 1.06% based on previous share price of Rs. 1936.5.
2. What are the returns for Gland Pharma share?
Return Performance of Gland Pharma Shares:
- 1 Week: Gland Pharma share price moved up by 0.75%
- 6 Month: Gland Pharma share price moved up by 33.70%
3. What is 52 week high/low of Gland Pharma share price?
In last 52 weeks Gland Pharma share had a high price of Rs 2,131.00 and low price of Rs 1,277.80
4. What is the PE & PB ratio of Gland Pharma?
The PE ratio of Gland Pharma stands at 41.02, while the PB ratio is 3.45.
5. What is the market cap of Gland Pharma?
Market Capitalization of Gland Pharma stock is Rs 31,926.50 Cr.

Trending in Markets

Top Gainers As on 03:59 PM | 17 Oct 2025

Netweb Technologies3,833.10

2026.30 (112.15%)

HBL Power936.05

334.85 (55.70%)

Anand Rathi Wealth3,125.10

1082.20 (52.97%)

Syrma SGS Technology787.00

258.00 (48.77%)

Usha Martin455.30

145.50 (46.97%)

Top Losers As on 03:59 PM | 17 Oct 2025

Tata Investment889.00

-5995.00 (-87.09%)

Adani Power165.98

-401.17 (-70.73%)

Patanjali Foods587.85

-1092.15 (-65.01%)

Godfrey Philips3,411.70

-4767.30 (-58.29%)

SKF India2,219.60

-2457.00 (-52.54%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

ETPrime

Gland Pharma Share Price

Key Metrics

Gland Pharma share price insights

InsightsGland Pharma

Key Metrics

Gland Pharma Share Price Returns

ET Stock ScreenersTop Score Companies

Gland Pharma News & Analysis

Gland Pharma Share Recommendations

Recent Recos

Analyst Trends

Gland Pharma Financials

Insights

Financial InsightsGland Pharma

Gland Pharma Share Price Forecast

Get multiple analysts’ prediction on Gland Pharma

Get multiple analysts’ prediction on Gland Pharma

Get multiple analysts’ prediction on Gland Pharma

Gland Pharma Technicals

Gland Pharma Peer Comparison

Ratio Performance

Peers InsightsGland Pharma

Gland Pharma Shareholding Pattern

Gland Pharma MF Ownership

HDFC Mid Cap Direct-G

SBI Large & Midcap Direct-G

Mirae Asset Large & Midcap Direct-G

Gland Pharma Corporate Actions

About Gland Pharma

Executives

Auditors

More Details

FAQs about Gland Pharma share

Trending in Markets

Top Gainers As on 03:59 PM | 17 Oct 2025

Top Losers As on 03:59 PM | 17 Oct 2025

Gland Pharma Quick Links

Equity Quick Links

More from Markets

1 Day	0.83%
1 Week	0.74%
1 Month	-2.6%
3 Months	-3.58%
1 Year	18.08%
3 Years	-10.14%
5 Years	N.A.